Article
A proteomic approach to investigate the role of the MECP2 gene mutation in Rett syndrome redox regulatory pathways.
Archives of biochemistry and biophysics - 1 Feb 2024
Pasqui Arianna, Cicaloni Vittoria, Tinti Laura, Guiotto Anna, Tinti Cristina, Mori Alessia, Bruttini Marco, Hayek Joussef, Pecorelli Alessandra, Salvini Laura, Valacchi Giuseppe
Abstract excerpt
Mutations in the X-linked methyl-CpG-binding 2 (MECP2) gene lead to Rett Syndrome (RTT; OMIM 312750), a devasting neurodevelopmental disorder. RTT clinical manifestations are complex and with different degrees of severity, going from autistic-like behavior to loss of acquired speech, motor skills and cardiac problems. Furthermore, the correlation between the type of MECP2 mutation and the clinical phenotype is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
